Dermatan sulfate

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Summary

Dermatan sulfate is a medication indicated to prevent deep vein thrombosis.

Generic Name
Dermatan sulfate
DrugBank Accession Number
DB15880
Background

Not Available

Type
Small Molecule
Groups
Experimental
Synonyms
  • beta-Heparin
  • Chondroitin sulfate B
  • Chondroitinsulfuric acid type B
  • Dermatan 4-sulfate
  • Dermatan hydrogen sulfate
  • Dermatan L-iduronate
  • Dermatan sulfate, low molecular weight
  • Dermatan sulphate
External IDs
  • MF 701
  • MF-701

Pharmacology

Indication

Not Available

Pharmacology
Accelerate your drug discovery research with the industry’s only fully connected ADMET dataset, ideal for:
Machine Learning
Data Science
Drug Discovery
Accelerate your drug discovery research with our fully connected ADMET dataset
Learn more
Associated Conditions
Contraindications & Blackbox Warnings
Contraindications
Contraindications & Blackbox Warnings
With our commercial data, access important information on dangerous risks, contraindications, and adverse effects.
Learn more
Our Blackbox Warnings cover Risks, Contraindications, and Adverse Effects
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Medicalerrors
Reduce medical errors
and improve treatment outcomes with our comprehensive & structured data on drug adverse effects.
Learn more
Reduce medical errors & improve treatment outcomes with our adverse effects data
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AbciximabThe risk or severity of bleeding can be increased when Abciximab is combined with Dermatan sulfate.
AceclofenacThe risk or severity of bleeding and hemorrhage can be increased when Aceclofenac is combined with Dermatan sulfate.
AcemetacinThe risk or severity of bleeding and hemorrhage can be increased when Acemetacin is combined with Dermatan sulfate.
AcenocoumarolThe risk or severity of bleeding can be increased when Acenocoumarol is combined with Dermatan sulfate.
Acetylsalicylic acidAcetylsalicylic acid may increase the anticoagulant activities of Dermatan sulfate.
Albutrepenonacog alfaThe therapeutic efficacy of Albutrepenonacog alfa can be decreased when used in combination with Dermatan sulfate.
AlclofenacThe risk or severity of bleeding and hemorrhage can be increased when Alclofenac is combined with Dermatan sulfate.
AldesleukinThe risk or severity of bleeding can be increased when Dermatan sulfate is combined with Aldesleukin.
AlemtuzumabThe risk or severity of bleeding can be increased when Dermatan sulfate is combined with Alemtuzumab.
AlteplaseThe risk or severity of bleeding can be increased when Alteplase is combined with Dermatan sulfate.
Interactions
Improve patient outcomes
Build effective decision support tools with the industry’s most comprehensive drug-drug interaction checker.
Learn more
Food Interactions
Not Available

Products

Products
Comprehensive & structured drug product info
From application numbers to product codes, connect different identifiers through our commercial datasets.
Learn more
Easily connect various identifiers back to our datasets
Learn more
Product Ingredients
IngredientUNIICASInChI Key
Dermatan sulfate sodiumNot AvailableNot AvailableNot applicable

Categories

ATC Codes
B01AX04 — Dermatan sulfate
Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
J3OC7JVS54
CAS number
24967-94-0

References

General References
  1. AIFA Product Information: MISTRAL (dermatan sulfate) injection [Link]
Wikipedia
Dermatan_sulfate

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Injection, solutionIntramuscular
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
Not Available
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Drug created on September 24, 2020 17:17 / Updated on May 07, 2021 21:08